GT BIOPHARMA INC (GTBP)
US36254L3087 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.08M | 5.70M | 9.00M | 5.30M | 0.00 | |||
| Marketable Securities | 12.89M | 10.80M | 23.00M | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 84.00K | 100.00K | 200.00K | 400.00K | 200.00K | |||
| Total Current Assets | 14.06M | 16.60M | 32.20M | 5.70M | 300.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 53.00K | 200.00K | N/A | 0.00 | 100.00K | |||
| Intangibles | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Assets | N/A | 0.00 | N/A | 0.00 | 0.00 | |||
| Total Non-Current Assets | 53.00K | 100.00K | 0.00 | 0.00 | 100.00K | |||
| TOTAL ASSETS | 14.11M | 16.70M | 32.20M | 5.70M | 400.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 26.30M | 13.20M | |||
| Accrued Expenses | 1.25M | 1.80M | 1.90M | 6.10M | 4.50M | |||
| Accounts Payable | 4.33M | 3.10M | 8.20M | 2.20M | 1.90M | |||
| Other Current Liabilities | 1.05M | 0.00 | 100.00K | 400.00K | 0.00 | |||
| Total Current Liabilities | 6.63M | 4.90M | 10.30M | 35.10M | 19.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | 100.00K | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 100.00K | 0.00 | -200.00K | -200.00K | |||
| TOTAL LIABILITIES | 6.63M | 5.00M | 10.30M | 34.90M | 19.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -682.07M | -674.50M | -653.60M | -595.60M | -567.30M | |||
| Additional Paid In Capital | 689.54M | 686.20M | 674.30M | 566.30M | 548.10M | |||
| Minority Interest | N/A | N/A | N/A | -200.00K | -200.00K | |||
| Common Shares | 2.00K | 0.00 | 1.10M | 100.00K | 100.00K | |||
| Shares Outstanding | 1.38M | 32.70M | 32.10M | 5.20M | 4.10M | |||
| Tangible Book Value per Share | 5.41 | 0.36 | 0.68 | -5.63 | -4.66 | |||
| Total Shareholders' Equity | 7.48M | 11.70M | 21.90M | -29.30M | -19.10M | |||
| TOTAL LIABILITIES AND EQUITY | 14.11M | 16.70M | 32.20M | 5.70M | 400.00K | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 2.12 | 3.39 | 3.13 | 0.16 | 0.02 | |||
| Return On Assets (ROA) | -53.85% | -125.03% | -180.16% | -496.49% | -9662.50% | |||
| Return On Equity (ROE) | -101.62% | -178.46% | -264.89% | N/A | N/A | |||
All data in USD